International union of basic and clinical pharmacology. XCVII. G protein–coupled estrogen receptor and its pharmacologic modulators

ER Prossnitz, JB Arterburn - Pharmacological reviews, 2015 - ASPET
Estrogens are critical mediators of multiple and diverse physiologic effects throughout the
body in both sexes, including the reproductive, cardiovascular, endocrine, nervous, and …

[HTML][HTML] Estrogen signaling and its potential as a target for therapy in ovarian cancer

SP Langdon, CS Herrington, RL Hollis, C Gourley - Cancers, 2020 - mdpi.com
The estrogen receptor (ER) has functionality in selected ovarian cancer subtypes and
represents a potential target for therapy. The majority (> 80%) of high grade serous, low …

[HTML][HTML] Expression and role of the G protein-coupled estrogen receptor (GPR30/GPER) in the development and immune response in female reproductive cancers

CD Hernández-Silva, JC Villegas-Pineda… - Frontiers in …, 2020 - frontiersin.org
Cancer is a major public health issue and represents the second leading cause of death in
women worldwide, as female reproductive-related neoplasms are the main cause of …

[HTML][HTML] Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications

H Li, Y Liu, Y Wang, X Zhao, X Qi - Oncology reports, 2021 - spandidos-publications.com
Ovarian cancer (OC) remains the leading cause of mortality due to gynecological
malignancies. Epidemiological studies have demonstrated that steroid hormones released …

[HTML][HTML] Estrogen receptors-mediated apoptosis in hormone-dependent cancers

A Chimento, A De Luca, P Avena, F De Amicis… - International journal of …, 2022 - mdpi.com
It is known that estrogen stimulates growth and inhibits apoptosis through estrogen receptor
(ER)-mediated mechanisms in many cancer cell types. Interestingly, there is strong evidence …

[HTML][HTML] Molecular characterization of membrane steroid receptors in hormone-sensitive cancers

M Masi, M Racchi, C Travelli, E Corsini, E Buoso - Cells, 2021 - mdpi.com
Cancer is one of the most common causes of death worldwide, and its development is a
result of the complex interaction of genetic factors, environmental cues, and aging. Hormone …

G protein–coupled estrogen receptor regulates mammary tumorigenesis and metastasis

NA Marjon, C Hu, HJ Hathaway, ER Prossnitz - Molecular Cancer Research, 2014 - AACR
The role of 17β-estradiol (E2) in breast cancer development and tumor growth has
traditionally been attributed exclusively to the activation of estrogen receptor-α (ERα) …

Bisphenol A and nonylphenol have the potential to stimulate the migration of ovarian cancer cells by inducing epithelial–mesenchymal transition via an estrogen …

YS Kim, KA Hwang, SH Hyun, KH Nam… - Chemical Research …, 2015 - ACS Publications
Epithelial–mesenchymal transition (EMT) is an important process appearing in embryo
development and tumor migration or progression, which is influenced by 17β-estradiol (E2) …

The G protein-coupled estrogen receptor as a modulator of neoplastic transformation

D Jacenik, AI Cygankiewicz, WM Krajewska - Molecular and cellular …, 2016 - Elsevier
Estrogens play a crucial role in the regulation of physiological and pathophysiological
processes. These hormones act through specific receptors, most notably the canonical …

Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonist

Q Ding, J Chorazyczewski, R Gros… - Pharmacology …, 2022 - Wiley Online Library
Aldosterone exerts some of its effects not by binding to mineralocorticoid receptors, but
rather by acting via G protein‐coupled estrogen receptors (GPER). To determine if …